Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels

Brain Research

Volumn 758, Issue 1-2, 1997, Pages 83-91

  De Boer, P ^a   Enrico, P ^a,b   Wright, J ^a,c   Wise, L D ^a,c   Timmerman, W ^a   Moor, E ^a   Dijkstra, D ^a   Wikstrom H V ^a   Westerink, B H C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF SASSARI   (Italy)

^c PFIZER INC   (United States)

Author keywords

Accumbens; Amphetamine; D3 receptor; Extracellular dopamine level; Haloperidol; Locomotor activity; PD128907; PD151328; R (+) 7 OH DPAT; Striatum

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; AMPHETAMINE; DOPAMINE; DOPAMINE 3 RECEPTOR; HALOPERIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; LIMBIC CORTEX; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STRIATE CORTEX;

ANIMALS; BENZOPYRANS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; OXAZINES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TETRAHYDRONAPHTHALENES;

EID: 0030757435     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01438-2     Document Type: Article

References (32)

1. M. Abou-Gharbia, Sigma receptors and their ligands: the sigma enigma, Annu. Rep. Med. Chem. 28 (1993) 1-10.
2. S. Ahlenius, P. Salmi, Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat, Eur. J. Pharmacol. 260 (1994) 177-181.
3. 3H]PD128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cells, Life Sci. 57 (1995) 1401-1410.
4. L.J. Bristow, G.P. Cook, J.C. Gay, J.J. Kulagowski, L. Landon, F. Murray, K.L. Saywell, L. Young, P.H. Hutson, The behavioural and neurochemical profile of the putative dopamine D3 receptor agonist, (+)-PD 128907, in the rat, Neuropharmacology 35 (1996) 285-294.
5. C.L. Chio, M.E. Lajiness, R.M. Huff, Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopmine receptors, Mol. Pharmacol. 45 (1994) 51-60.
6. O. Civelli, J.R. Bunzow, D.K. Grandy, Molecular diversity of the dopamine receptor, Annu. Rev. Pharmacol. Toxicol. 33 (1993) 281-307.
7. S.A. Daly, J.L. Waddington, Behavioral effects of the putative D3 dopamine receptor agonist 7-OH-DPAT in relation to other "D2-like" agonists, Neuropharmacology 32 (1993) 509-510.
8. G. Damsma, T. Bottema, B.H.C. Westerink, P.G. Tepper, D. Dijkstra, T.A. Pugsley, R.G. MacKenzie, T.G. Heffner, H.V. Wikström, Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand, Eur. J. Pharmacol. 249 (1993) R9-R10.
9. a values for central dopamine receptor activation, J. Med. Chem. 31 (1988) 2178-2182.
10. S.B. Freedman, S. Patel, R. Marwood, F. Emms, G.R. Seabrook, M.R. Knowles, G. McAllister, Expression and pharmacological characterization of the human D3 dopamine receptor, J. Pharmacol. Exp. Ther. 268 (1994) 417-426.
11. J.W. Kebabian, D.B. Calne, Multiple receptors for dopamine, Nature 277 (1979) 93-96.
12. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin, Proc. Natl. Acad. Sci. USA 89 (1992) 8155-8259.
13. J.C. Liu, R.F. Cox, G.J. Greif, J.E. Freedman, B.L. Waszczak, The putative dopamine D3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivity, Eur. J. Pharmacol. 264 (1994) 269-278.
14. R.G. MacKenzie, D. Van Leeuwen, T.A. Pugsley, Y.H. Shih, S. Demattos, L. Tang, R.D. Todd, K.L. O'Malley, Characterization of the human dopamine D3 receptor expressed in transfected cell lines, Eur. J. Pharmacol. 266 (1994) 79-85.
15. E. Meller, K. Bohmaker, M. Goldstein, D.A. Basham, Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors, Eur. J. Pharmacol. 249 (1993) R5-R6.
16. H. Nissbrandt, A. Ekman, E. Eriksson, M. Heilig, Dopamine D3 receptor antisense influences dopamine synthesis in rat brain, NeuroReport 6 (1995) 573-576.
17. G. Paxinos, C. Watson, Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1992.
18. T.A. Pugsley, M.D. Davis, H.C. Akunne, R.G. MacKenzie, Y.H. Shih, G. Damsma, H. Wikström, S.Z. Whetzel, L.W. Cooke, S.B. DeMattos, A.E. Corbin, S.A. Glases, L.D. Wise, D. Dijkstra, T.G. Heffner, Neurochemical and functional characterization of the selective dopamine compound PD 128907, J. Pharmacol. Exp. Ther. 275 (1995) 1355-1366.
19. J.M. Rivet, V. Audinot, A. Gobert, J.L. Peglion, M.J. Millan, Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S14297, Eur. J. Pharmacol. 265 (1994) 175-177.
20. M. Santiago, B.H.C. Westerink, Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes, Naunyn-Schmiedeberg's Arch. Pharmacol 343 (1990) 407-414.
21. F. Sautel, N. Griffon, D. Levesque, C. Pilon, J.C. Schwartz, P. Sokoloff, A functional test identifies dopamine agonists selective for D3 versus D2 receptors, NeuroReport 6 (1995) 329-332.
22. 3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus, Eur. J. Pharmacol. 242 (1993) R1-R2.
23. P. Sokoloff, B. Giros, M.P. Martres, M.L. Bouthenet, J.C. Schwartz, Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics, Nature 347 (1990) 146-151.
24. L. Ståhle, Do autoreceptors mediate dopamine agonist-induced yawning and suppression of exploration? A critical review, Psychopharmacology (Berlin) 106 (1992) 1-13.
25. K. Svensson, A. Carlsson, N. Waters, Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release, J. Neural Transm. (Gen. Sect.) 95 (1994) 71-74.
26. J.M. Van Ree, G. Wolterink, Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity, Eur. J. Pharmacol. 72 (1981) 107-111.
27. H. Wachtel, S. Ahlenius, N.E. Andén, Effects of locally applied dopamine to the nucleus accumbens on motor activity of normal rats and following α-methyltyrosine or reserpine, Psychopharmacology (Berlin) 63 (1979) 203-206.
28. 3H]propyl-2-aminotetralin and carbapentane, J. Neurochem. 64 (1995) 700-710.
29. 3 receptor: a postsynaptic receptor in hibitory on rat locomotor activity, J. Neural Transm. (Gen. Sect.) 94 (1993) 11-19.
30. J. Wright, T. Heffner, T. Pugsley, R. MacKenzie, L. Wise, Discovery of selective dopamine D3 ligands II. 2-[4-[3-(4-aryl-1-piperazinyl)propoxy]benzimidazole partial agonists, Biorg. Med. Chem. Lett. 5 (1995) 2547-2550.
31. S. Yamada, H. Yokoo, S. Nishi, Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats, Brain Res. 648 (1994) 176-179.
32. S. Yamada, T. Takaki, H. Yokoo, M. Tanaka, Differential effects of dopamine antagonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats, J. Pharm. Pharmacol. 47 (1995) 259-262.